Search Results 91-100 of 16265 for monoclonal antibody

  1. Mayo Clinic research finds immune system responds to mRNA treatment for cancer

    Dong and his team produced an immune system protein in the lab ― a monoclonal antibody ― that can detect the protein levels in tumor tissues. The goal was ...

  2. Cancer to COVID-19: Experimental treatment pivots in record time - Mayo Clinic News Network

    But then the pandemic started. Literature Lightbulb. Lenzilumab is a monoclonal antibody drug. Read more about monoclonal antibodies in, "Monoclonal Antibodies: ...

  3. OCEAN (depemOkimab effiCacy Eosinophilic grAnulomatosis with polyaNgiitis) - Mayo Clinic

    Depemokimab is a humanised, affinity matured monoclonal antibody that blocks human interleukin-5 (IL-5) binding to its receptor. Depemokimab is being ...

  4. Brentuximab Vedotin and Nivolumab With or Without Ipilimumab in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma - Mayo Clinic

    Brentuximab vedotin is a combining monoclonal antibody with an anticancer drug that binds to a protein on the surface of lymphoma cells called cluster of ...

  5. Anifrolumab-fnia (intravenous route) - Mayo Clinic

    It is a monoclonal antibody that changes the immune system to help control lupus symptoms. This medicine is available only with your doctor's prescription ...

  6. A Study to Evaluate Acalabrutinib With or Without Obinutuzumab to Treat Early-Stage Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Patients - Mayo Clinic

    Acalabrutinib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Monoclonal antibodies, such as obinutuzumab, may ...

  7. Testing the Addition of a New Drug, Venetoclax, to the Usual Treatment (Ibrutinib and Rituximab) for Waldenstrom's Macroglobulinemia/Lymphoplasmacytic Lymphoma - Mayo Clinic

    Ibrutinib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Rituximab is a monoclonal antibody that may interfere with ...

  8. Studying the Effect of Denosumab on Preventing Breast Cancer in Women With a BRCA1 Germline Mutation - Mayo Clinic

    Denosumab is a monoclonal antibody that is used to treat bone loss in order to reduce the risk of bone fractures in healthy people, and to reduce new bone ...

  9. Hong Qin, M.D., Ph.D. - Mayo Clinic Faculty Profiles

    Qin's antibody discovery research is focused on developing monoclonal antibodies against both well‐characterized and unknown antigens. To accomplish the former ...

  10. Idecabtagene vicleucel (intravenous route) - Mayo Clinic

    ... monoclonal antibody, a proteasome inhibitor, and an immunomodulatory agent) that did not work well. Idecabtagene vicleucel injection is an antineoplastic ...